USA Healthcare News Updates

 The  U.S. healthcare assets management market size  is projected to reach USD 50.00 billion by 2027, exhibiting a CAGR of 30.9% during the forecast period. Escalating hospital admissions in the US associated with the coronavirus will spawn lucrative opportunities in this market, states Fortune Business Insights™ in its report, titled “U.S. Healthcare Assets Management Market Size, Share & Covid-19 Impact Analysis, By Product (Radiofrequency Identification (RFID), Real-time Location Systems (RTLS), and Others), By Application (Staff Management, Equipment Tracking, Patient Tracking, and Supply Chain Management), and By End User (Hospitals, Laboratories, and Others), 2020-2027”. The United States has been one of the worst-hit countries by the COVID-19 pandemic, with the country having over 10 million cases and an average 900 deaths daily. Hospital admissions have skyrocketed across the country. According to the Centers for Disease Control and Prevention (CDC), betw...

The global  electronic health records (EHR) market  is set to gain momentum from the introduction to artificial intelligence (AI) in the healthcare industry. AI not only helps clinicians in diagnosing a patient’s condition, but also recognizes historical trends of the patient. This information is given by Fortune Business Insights™ in a recently published report, titled, “Electronic Health Records (EHR) Market Size, Share & Industry Analysis, By Product (Web-based, On-premise), By Type (Stand Alone, Integrated) By End User (Physician’s Office, Hospitals, Others) and Regional Forecast, 2019-2026.” The report further states that the EHR market size stood at USD 26,200.48 Million in 2018 and is projected to reach USD 39,913.16 Million by 2026, exhibiting a CAGR of 5.4% during the forecast period. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/electronic-health-records-ehr-market-102660 Below are a ...

The global  spectacles market  is projected to reach  USD 141.54 billion , thereby exhibiting a CAGR of 5.7% during the forecast period.  Fortune Business Insights™  published this information in a recent report, titled, “Spectacles Market Size, Share & Industry Analysis, By Product Type (Spectacles Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional.” The report further mentions that the market stood at  USD 91.56 billion  in 2018. However, it is expected to gain momentum from the rising prevalence of ocular disorders, such as myopia, hypermetropia, and astigmatism. Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/spectacles-market-101953 Industry Developments : July 2019:  EssilorLuxottica announced that the company is planning to buy 76.72% stakes in GrandVision, a Dutch optical r...

The global  continuous renal replacement therapy (CRRT) market  is set to be positively impacted by rising technological advancements by renowned acute therapy manufacturers to offer enhanced dialysis care worldwide. Also, the expansion of extracorporeal therapies taking place in the ICU would affect the market positively. This information is given by Fortune Business Insights™ in a recent report, titled, “Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Industry Analysis, By Product (Systems, and Consumables), By Modality (Slow continuous ultra-filtration {SCUF}, Continuous Venovenous Hemofiltration {CVVH}, Continuous Venovenous Haemodialysis {CVVHD}, and Continuous Venovenous Hemodiafiltration {CVVHDF), and Regional Forecast, 2019-2026.” The report further mentions that the CRRT market size was USD 845.7 million in 2018, and is projected to reach USD 1,502.1 million by 2026, exhibiting a CAGR of 7.5% during the forecast period. Request a Sample Copy ...

 The global  airway management devices market  size was valued at USD 1.81 billion in 2021 and is projected to reach a valuation of USD 1.89 billion in 2022. The market is expected to reach USD 2.55 billion by 2029 with a CAGR of 4.4% during the forecast period. Owing to rising cases of chronic diseases such as chronic obstructive pulmonary disease (COPD), cancer, chronic lung diseases, and others have put emphasis on better treatment of such conditions. Rising number of joint ventures and start-ups is projected to aid market development.  Fortune Business Insights™  shares this information in its report titled “ Airway Management Devices Market, 2022-2029. ” Get Sample PDF Brochure:   https://www.fortunebusinessinsights.com/enquiry/sample/airway-management-devices-market-107396 Key Industry Development January 2022-  Intersurgical Ltd announced the acquisition of Pulmodyne, Inc. to provide Intersurgical and for increased sa...

The global  critical care antiarrhythmic drugs market  size is projected to reach USD 1,319.7 million by 2027, exhibiting a CAGR of 5.6% during the forecast period. Increasing prevalence of cardiovascular diseases (CVDs) around the world will be a major growth determinant for this market, highlights Fortune Business Insights™ in its report, titled “Critical Care Antiarrhythmic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Calcium Channel Blockers, Sodium Channel Blockers, Potassium Channel Blockers, and Others),  By Disease Type (Supraventricular Arrhythmias, Ventricular Arrhythmias, and Others), and Regional Forecast, 2020-2027”. According to the World Health Organization (WHO), CVDs are the premier cause of global deaths, killing nearly 17.9 million people worldwide in 2016. Atrial fibrillation (AF) is the most frequent and the most commonly observed CVD. For example, the American Heart Association estimates that AF affects ...

The global  preeclampsia diagnostics market  size was valued at USD 1.03 billion in 2021 and reached USD 1.07 billion in 2022. The market is expected to reach USD 1.24 billion by 2029, exhibiting a CAGR of 2.2% during the forecast period. The rising prevalence of preeclampsia and increasing technological advancements in diagnostics procedures are expected to foster industry growth. Fortune Business Insights™ presents this information in its report titled “Preeclampsia Diagnostics Market, 2022-2029.” Key Industry Development July 2021:  LifeCell Diagnostics announced a comprehensive preeclampsia screening in India. The advanced screening detects biomarker, sFLT-1 (soluble FMS-like tyrosine kinase-1), which enables the prediction of the disease and helps in accurate diagnosis even in the third trimester. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/preeclampsia-diagnostics...